RecQ Clinical Oy is a limited company based in Helsinki, registered in 2018. In the financial year ending 31.12.2025, revenue was 673 t€ and operating profit 195 t€; equity ratio 76.5 %. Its taxable income in 2024 was 169 t€ and its income taxes 34 t€.
Revenue 2025673 t€-25 % on the previous year
Operating profit195 t€29,0 % of revenue
Net profit148 t€EBITDA 189 t€
Equity ratio76,5 %quick ratio 3,84
Taxable income 2024169 t€
top quarter of its industry
Income taxes 202434 t€130 t€ in 2020–2024
In business7 yrsregistered 15.11.2018
Helsinki: 289 new companies in 30 days
- Mixedtape Group OyRuokaravintolat
- Bella Creative OyMuu esittävä taide
- LHT Solutions OyPuhelinpalvelukeskusten toiminta
Try for free
Get your area's new companies by email every morning. 14 days, no card needed.
Financials
RevenueOperating profitNet profit
| Key figures | 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | 31.12.2021 | 31.12.2020 |
|---|---|---|---|---|---|---|
| Revenue | 673 t€ | 899 t€ | 824 t€ | 567 t€ | 296 t€ | 256 t€ |
| Revenue change | -25,2 % | 9,1 % | 45,3 % | 91,4 % | 15,7 % | – |
| EBITDA | 189 t€ | 342 t€ | 251 t€ | 221 t€ | 107 t€ | 80 t€ |
| EBITDA % | 28,0 % | 38,0 % | 30,5 % | 38,9 % | 36,1 % | 31,1 % |
| Operating profit | 195 t€ | 337 t€ | 248 t€ | 221 t€ | 107 t€ | 64 t€ |
| Operating margin | 29,0 % | 37,5 % | 30,1 % | 38,9 % | 36,1 % | 24,8 % |
| Net profit | 148 t€ | 134 t€ | 118 t€ | 123 t€ | 85 t€ | 50 t€ |
| Personnel costs | -23 t€ | 104 t€ | 110 t€ | 117 t€ | 57 t€ | 62 t€ |
| Equity ratio | 76,5 % | 81,0 % | 64,2 % | 75,5 % | 81,2 % | 44,4 % |
| Quick ratio | 3,84 | 4,85 | 2,65 | 4,08 | 5,31 | 2,58 |
| Current ratio | 3,84 | 4,85 | 2,65 | 4,08 | 5,31 | 2,58 |
| Debt to revenue | 7,2 % | 3,7 % | 8,4 % | 7,2 % | 6,9 % | 29,1 % |
| Return on equity | 93,5 % | 95,5 % | 95,3 % | 97,8 % | 97,2 % | 83,3 % |
| Balance sheet total | 207 t€ | 173 t€ | 192 t€ | 167 t€ | 108 t€ | 134 t€ |
| Equity | 158 t€ | 140 t€ | 123 t€ | 126 t€ | 88 t€ | 60 t€ |
| Cash and bank | 32 t€ | 49 t€ | 48 t€ | 45 t€ | 70 t€ | 55 t€ |
Balance sheet
Balance sheet totalEquityCash
Income statement and balance sheet
Income statement
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | 31.12.2021 | 31.12.2020 | |
|---|---|---|---|---|---|---|
| Turnover | 673 t€ | 899 t€ | 824 t€ | 567 t€ | 296 t€ | 256 t€ |
| Other operating income | 0 € | -680 € | -11 € | 0 € | 0 € | 10 t€ |
| Raw materials and services | 189 t€ | -148 t€ | -106 t€ | -19 t€ | -107 € | -9 001 € |
| Personnel expenses | 23 t€ | -104 t€ | -110 t€ | -117 t€ | -57 t€ | -62 t€ |
| Depreciations and reductions in value | 6 693 € | -4 583 € | -3 370 € | 0 € | 0 € | -16 t€ |
| Other operating expenses | 258 t€ | -305 t€ | -357 t€ | -210 t€ | -132 t€ | -115 t€ |
| Operating profit (loss) | 195 t€ | 337 t€ | 248 t€ | 221 t€ | 107 t€ | 64 t€ |
| Financial income and expenses + (-) | -77 € | -29 € | 52 € | -1 € | -344 € | -1 111 € |
| Profit (loss) before appropriations and taxes | 195 t€ | 337 t€ | 248 t€ | 221 t€ | 107 t€ | 62 t€ |
| Income taxes | 37 t€ | -33 t€ | -30 t€ | -31 t€ | -21 t€ | -13 t€ |
| Profit (loss) for the financial year | 148 t€ | 134 t€ | 118 t€ | 123 t€ | 85 t€ | 50 t€ |
Balance sheet
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | 31.12.2021 | 31.12.2020 | |
|---|---|---|---|---|---|---|
| Non-current assets | 20 t€ | 14 t€ | 10 t€ | 0 € | 0 € | 48 t€ |
| Receivables | 155 t€ | 111 t€ | 134 t€ | 122 t€ | 38 t€ | 31 t€ |
| Cash in hand and at banks | 32 t€ | 49 t€ | 48 t€ | 45 t€ | 70 t€ | 55 t€ |
| Current assets | 187 t€ | 159 t€ | 182 t€ | 167 t€ | 108 t€ | 86 t€ |
| Assets | 207 t€ | 173 t€ | 192 t€ | 167 t€ | 108 t€ | 134 t€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 158 t€ | 140 t€ | 123 t€ | 126 t€ | 88 t€ | 60 t€ |
| Long-term liabilities | – | – | – | – | 0 € | 41 t€ |
| Short-term liabilities | 49 t€ | 33 t€ | 69 t€ | 41 t€ | 20 t€ | 33 t€ |
| Liabilities | 49 t€ | 33 t€ | 69 t€ | 41 t€ | 20 t€ | 75 t€ |
All financial statement items (48)
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | 31.12.2021 | 31.12.2020 | |
|---|---|---|---|---|---|---|
| Turnover | 673 t€ | 899 t€ | 824 t€ | 567 t€ | 296 t€ | 256 t€ |
| Other operating income | 0 € | -680 € | -11 € | 0 € | 0 € | 10 t€ |
| Raw materials and services | 189 t€ | -148 t€ | -106 t€ | -19 t€ | -107 € | -9 001 € |
| Personnel expenses | 23 t€ | -104 t€ | -110 t€ | -117 t€ | -57 t€ | -62 t€ |
| Depreciations and reductions in value | 6 693 € | -4 583 € | -3 370 € | 0 € | 0 € | -16 t€ |
| Other operating expenses | 258 t€ | -305 t€ | -357 t€ | -210 t€ | -132 t€ | -115 t€ |
| Operating profit (loss) | 195 t€ | 337 t€ | 248 t€ | 221 t€ | 107 t€ | 64 t€ |
| Financial income and expenses + (-) | -77 € | -29 € | 52 € | -1 € | -344 € | -1 111 € |
| Profit (loss) before appropriations and taxes | 195 t€ | 337 t€ | 248 t€ | 221 t€ | 107 t€ | 62 t€ |
| Income taxes | 37 t€ | -33 t€ | -30 t€ | -31 t€ | -21 t€ | -13 t€ |
| Profit (loss) for the financial year | 148 t€ | 134 t€ | 118 t€ | 123 t€ | 85 t€ | 50 t€ |
| Non-current assets | 20 t€ | 14 t€ | 10 t€ | 0 € | 0 € | 48 t€ |
| Receivables | 155 t€ | 111 t€ | 134 t€ | 122 t€ | 38 t€ | 31 t€ |
| Cash in hand and at banks | 32 t€ | 49 t€ | 48 t€ | 45 t€ | 70 t€ | 55 t€ |
| Current assets | 187 t€ | 159 t€ | 182 t€ | 167 t€ | 108 t€ | 86 t€ |
| Assets | 207 t€ | 173 t€ | 192 t€ | 167 t€ | 108 t€ | 134 t€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 158 t€ | 140 t€ | 123 t€ | 126 t€ | 88 t€ | 60 t€ |
| Long-term liabilities | – | – | – | – | 0 € | 41 t€ |
| Short-term liabilities | 49 t€ | 33 t€ | 69 t€ | 41 t€ | 20 t€ | 33 t€ |
| Liabilities | 49 t€ | 33 t€ | 69 t€ | 41 t€ | 20 t€ | 75 t€ |
| Reserve for invested non-restricted equity | – | – | – | – | 0 € | 2 266 € |
| Other interest and financial income from Group companies | 0 € | 42 € | 0 € | – | – | – |
| Profit (loss) for the period, equity | 148 t€ | 134 t€ | 118 t€ | 123 t€ | 85 t€ | 50 t€ |
| Machinery and equipment | 20 t€ | 14 t€ | 10 t€ | 0 € | 0 € | 48 t€ |
| Long-term accounts payable | – | – | – | – | 0 € | 41 t€ |
| Pension expenses | 3 233 € | -16 t€ | -16 t€ | -18 t€ | -8 451 € | -8 891 € |
| Short-term loan receivables | – | – | 0 € | 1 000 € | 1 000 € | 1 000 € |
| Short-term accounts payable | 28 t€ | 25 t€ | 58 t€ | 26 t€ | 11 t€ | 12 t€ |
| Short-term prepayments and accrued income | 7 592 € | 7 478 € | 20 t€ | 817 € | 871 € | 11 t€ |
| Liabilities | 207 t€ | 173 t€ | 192 t€ | 167 t€ | 108 t€ | 134 t€ |
| Other interest and financial income from non-group companies | 97 € | 10 € | 52 € | 0 € | – | – |
| Short-term liabilities to Group companies | – | – | – | – | 0 € | 16 t€ |
| Short-term accrued expenses and deferred income | 14 t€ | 6 100 € | 9 723 € | 12 t€ | 6 651 € | 3 865 € |
| Short-term sales receivables | 81 t€ | 72 t€ | 99 t€ | 117 t€ | 31 t€ | 15 t€ |
| Interest expenses and other financial expenses for non-Group companies | 20 € | -81 € | 0 € | -1 € | -344 € | -1 111 € |
| Other current liabilities | 6 571 € | 1 558 € | 1 603 € | 2 960 € | 2 776 € | 1 119 € |
| Short-term receivables | 155 t€ | 111 t€ | 134 t€ | 122 t€ | 38 t€ | 31 t€ |
| Other short-term receivables | 17 t€ | 11 t€ | 15 t€ | 3 348 € | 5 460 € | 5 029 € |
| Retained earnings | 7 777 € | 3 872 € | 3 302 € | 321 € | 0 € | 5 174 € |
| Depreciations according to plan | 6 693 € | -4 583 € | -3 370 € | 0 € | 0 € | -16 t€ |
| Tangible assets | 20 t€ | 14 t€ | 10 t€ | 0 € | 0 € | 48 t€ |
| Services purchased | 188 t€ | -146 t€ | -96 t€ | -10 t€ | 0 € | – |
| Current receivables from Group companies | 50 t€ | 20 t€ | 0 € | – | – | – |
| Group contribution | 10 t€ | -170 t€ | -100 t€ | -67 t€ | 0 € | – |
| Purchases during the financial year | 1 356 € | -2 169 € | -9 955 € | -9 280 € | -107 € | -9 001 € |
| Other social security expenses | 1 109 € | -1 877 € | -2 969 € | -2 604 € | -1 604 € | -2 035 € |
| Wages and salaries | 19 t€ | -87 t€ | -91 t€ | -97 t€ | -47 t€ | -51 t€ |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, RecQ Clinical Oy is in the top quarter of the industry class research and experimental development on natural sciences and engineering (326 companies with taxable income; median 34 t€, 5,0 times the median).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.